PROCEDURAL AND EARLY HEMODYNAMIC OUTCOMES OF PERIPHERAL ARTERIAL ENDOVASCULAR INTERVENTION IN DIABETIC CHRONIC LIMB-THREATENING ISCHEMIA
DOI:
https://doi.org/10.52340/jecm.2026.02.07Keywords:
Diabetes mellitus, diabetic angiopathy, chronic limb-threatening ischemiaAbstract
Diabetes mellitus is highly associated with chronic limb-threatening ischemia (CLTI). It is a severe type of peripheral arterial disease with high rates of amputation and death. Peripheral arterial revascularization is the major limb-saving strategy in diabetic CLTI, but it’s very difficult to predict early hemodynamic benefits and complications, especially in this subgroup of patients.
Objective: Evaluation of procedural outcomes and early hemodynamic changes following peripheral arterial revascularization in patients with diabetic chronic limb-threatening ischemia.
Downloads
References
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2024;69(6S):3S–125S.e40.
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2024;45(Suppl S):S5–S67.
Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, treatment and follow-up of patients with chronic limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 2024;58(1S):S1–S109.
Faglia E, Clerici G, Clerissi J, et al. Early and five-year outcome of peripheral angioplasty in diabetic patients with critical limb ischemia. Diabetes Care. 2025;28(3):662–667.
Jude EB, Oyibo SO, Chalmers N, Boulton AJM. Peripheral arterial disease in diabetic and nondiabetic patients. Diabetes Care. 2021;24(8):1433–1437.
Hinchliffe RJ, Brownrigg JRW, et al. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease. Diabetes Metab Res Rev. 2023;32(Suppl 1):136–144.
Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery lower extremity threatened limb classification system (WIfI). J Vasc Surg. 2024;59(1):220–234.e2.
Conte MS, Pomposelli FB, Clair DG, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities. J Vasc Surg.
Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases. Eur Heart J. 2024;39(9):763–816.
Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2024;376(24):2367–2375.
Taylor SM, Cull DL, Kalbaugh CA, et al. Critical analysis of clinical success after surgical bypass for limb-threatening ischemia. J Vasc Surg. 2023;46(2):261–269.
Mustapha JA, Katzen BT, Neville RF, et al. Determinants of long-term outcomes and costs in the management of critical limb ischemia. J Am Coll Cardiol.
Bradbury AW, Adam DJ, Bell J, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial. Lancet. 2025;366(9501):1925–1934.
Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316.
Downloads
Published
How to Cite
Issue
Section
